Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)

Clinical trial NCT03501550 · COMPLETED

Trial details

NCT number: NCT03501550
Sponsor: Cocrystal Pharma, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2018-06-26
Primary completion: 2019-01-08
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.